Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bithionol sulfoxide is an anthelmintic agent primarily utilized in veterinary medicine for the treatment of trematode infections, specifically liver flukes (*Fasciola* species) and rumen flukes (*Paramphistomum* species) in ruminants such as cattle, sheep, and goats. As a derivative of bithionol, it functions by uncoupling oxidative phosphorylation in the mitochondria of the parasites, thereby depleting their energy reserves and leading to paralysis and death. It is commonly formulated as an oral bolus for livestock. While the parent compound bithionol has been used in humans for paragonimiasis, the sulfoxide form is predominantly associated with veterinary applications and is manufactured as a generic formulation by companies such as Ambrosia Remedies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bithionol sulfoxide.